381 related articles for article (PubMed ID: 25066735)
1. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
[TBL] [Abstract][Full Text] [Related]
3. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
5. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
[TBL] [Abstract][Full Text] [Related]
6. Identification of an epitope within the Bovine herpesvirus 1 glycoprotein E cytoplasmic tail and use of a monoclonal antibody directed against the epitope for the differentiation between vaccinated and infected animals.
Chowdhury SI
J Virol Methods; 2016 Jul; 233():97-104. PubMed ID: 26976821
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
[TBL] [Abstract][Full Text] [Related]
8. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
9. Intraspecific bovine herpesvirus 1 recombinants carrying glycoprotein E deletion as a vaccine marker are virulent in cattle.
Muylkens B; Meurens F; Schynts F; Farnir F; Pourchet A; Bardiau M; Gogev S; Thiry J; Cuisenaire A; Vanderplasschen A; Thiry E
J Gen Virol; 2006 Aug; 87(Pt 8):2149-2154. PubMed ID: 16847110
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a triplex real-time PCR assay for the rapid detection and differentiation of wild-type and glycoprotein E-deleted vaccine strains of Bovine herpesvirus type 1.
Wernike K; Hoffmann B; Kalthoff D; König P; Beer M
J Virol Methods; 2011 Jun; 174(1-2):77-84. PubMed ID: 21458493
[TBL] [Abstract][Full Text] [Related]
11. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
[TBL] [Abstract][Full Text] [Related]
12. A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats.
Thiry J; Tempesta M; Camero M; Tarsitano E; Bellacicco AL; Thiry E; Buonavoglia C
Vet Microbiol; 2006 Mar; 113(3-4):303-8. PubMed ID: 16330168
[TBL] [Abstract][Full Text] [Related]
13. A glycoprotein E gene-deleted bovine herpesvirus 1 as a candidate vaccine strain.
Weiss M; Brum MC; Anziliero D; Weiblen R; Flores EF
Braz J Med Biol Res; 2015 Sep; 48(9):843-51. PubMed ID: 26200229
[TBL] [Abstract][Full Text] [Related]
14. Construction, characterization and immunogenicity of a glycoprotein E negative bovine herpesvirus-1.1 Egyptian strain "Abu-Hammad".
El-Kholy AA; Rady DI; Abdou ER; Elseafy MM; Abdelrahman KA; Soliman H
J Virol Methods; 2013 Dec; 194(1-2):74-81. PubMed ID: 23962750
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
[TBL] [Abstract][Full Text] [Related]
16. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
[TBL] [Abstract][Full Text] [Related]
17. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
[TBL] [Abstract][Full Text] [Related]
18. Long-term study (2005-2010) on the vaccination with BoHV-1 glycoprotein E-deleted marker vaccine in selected two dairy herds in Turkey.
Alkan F; Bilge-Dagalp S; Karapınar Z; Timurkan MO; Coskun N; Burgu I
Trop Anim Health Prod; 2018 Feb; 50(2):353-363. PubMed ID: 29071668
[TBL] [Abstract][Full Text] [Related]
19. Biological characterization of bovine herpesvirus 1 recombinants possessing the vaccine glycoprotein E negative phenotype.
Muylkens B; Meurens F; Schynts F; de Fays K; Pourchet A; Thiry J; Vanderplasschen A; Antoine N; Thiry E
Vet Microbiol; 2006 Mar; 113(3-4):283-91. PubMed ID: 16321480
[TBL] [Abstract][Full Text] [Related]
20. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
Wei H; He J; Paulsen DB; Chowdhury SI
Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
